PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Freitag Gregory Gene
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Glover Stephen C.
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Ali-Jackson Kamil
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director BRAWLEY OTIS W
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Iliev Ilian
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director SYKES RICHARD
PDS Biotechnology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.96%)
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Toutain Stephan
PDS Biotechnology | 3: Initial statement of beneficial ownership of securities-Officer Toutain Stephan
PDS Biotechnology | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.0%)
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Shepard Kirk V.
PDS Biotechnology | 3: Initial statement of beneficial ownership of securities-Officer Shepard Kirk V.
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Boesgaard Lars
PDS Biotechnology | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Boesgaard Lars
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Freitag Gregory Gene
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director BRAWLEY OTIS W
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Ali-Jackson Kamil
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director SYKES RICHARD
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Glover Stephen C.
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Iliev Ilian